Spots Global Cancer Trial Database for Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer Patients
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Laser Therapy for the Prevention of Radiodermatitis in Breast Cancer Patients
Official Title: Low-level Laser Therapy as a Tool for the Prevention of Radiodermatitis in Breast Cancer Patients
Study ID: NCT02443493
Conditions
Study Description
Brief Summary: Up to 90% of the radiotherapy patients will develop a certain degree of skin reaction at the treated area, also known as radiodermatitis (RD). Currently, there is a wide variety of strategies to manage RD, including creams, gels, ointments, wound dressings. However, up to now, there is still no comprehensive, evidence-based consensus for the treatment of RD. Low-level laser therapy (LLLT) is a promising, non-invasive technique for treating RD. In a recent pilot study conducted in our research group, LLLT prevented the aggravation of RD and provided symptomatic relief in patients undergoing radiotherapy for breast cancer after breast-sparing surgery. This pilot study was the first prospective study investigating the potential of LLLT for RD. In the current study, we want to investigate the efficacy of LLLT as a tool for the prevention of radiodermatitis in breast cancer patients.
Detailed Description:
Keywords
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: FEMALE
Healthy Volunteers: No
Locations
Jessa Hospital - Oncology department, Hasselt, , Belgium
Contact Details
Name: Jeroen Mebis, prof. dr.
Affiliation: Universiteit Hasselt/ Jessa ziekenhuis
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
